Radionuclide ventriculography detects early anthracycline cardiotoxity in children with Hodgkin lymphoma

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 4, 2011, Pages

  Tantawy, Azza A G ^a   Elmasry, Ola A ^a   Shaaban, Magdy ^a   Toaima, Dalia N ^a   El Shahat, Ali M ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

anthracycline; children; doxorubicin; echocardiography; radionuclide ventriculography

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; HUMAN SERUM ALBUMIN TC 99M; VINBLASTINE;

ADOLESCENT; ADULT; ARTICLE; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; M MODE ECHOCARDIOGRAPHY; MALE; MULTIPLE CYCLE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; CHILD, PRESCHOOL; DACARBAZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HEART DISEASES; HODGKIN DISEASE; HUMANS; MALE; RADIONUCLIDE VENTRICULOGRAPHY; STROKE VOLUME; VINBLASTINE;

EID: 79955501818     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318212eb6b     Document Type: Article

References (44)

1. Minotti G, Menna P, Salvatorelli E, et al. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56:185-229. (Pubitemid 38720829)
2. Lefrak EA, Pitha J, Rosenheim S, et al. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 1973;32: 302-314.
3. Pfeffer B, Tziros C, Katz RJ. Current concepts of anthracycline cardiotoxicity: pathogenesis, diagnosis and prevention. Br J Cardiol. 2009;16: 85-89.
4. Shuman RD, Ettinger DS, Abeloff MD, et al. Comparative analysis of non-invasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity. Johns Hopkins Med J. 1981;149:57-63. (Pubitemid 11040476)
5. Mitani I, Jain D, Joska TM, et al. Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era. J Nucl Cardiol. 2003;10:132-139. (Pubitemid 36503798)
6. Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf. 2000; 22:262-302.
7. Hauser M, Wilson N. Anthracycline induced cardiomyopathy: successful treatment with angiotensin converting enzyme inhibitors. Eur J Pediatr. 2000;159:389. (Pubitemid 30243647)
8. Simbre VC II, Adams MJ, Deshpande SS, et al. Cardiomyopathy caused by antineoplastic therapies. Curr Treat Options Cardiovasc Med. 2001;3:493-505.
9. Steinherz LJ, Graham T, Hurwitz R, et al. Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Children's Cancer Study Group. Pediatrics. 1992;89:942-949.
10. Ganz WI, Sridhar KS, Ganz SS, et al. Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncology. 1996;53:461-70. (Pubitemid 26388387)
11. Ewer MS, Ali MK, Mackay B, et al. A comparison of cardiac biopsy grades and ejection fraction estimation in patients recieving Anthracycline. J Clin Oncol. 1984;2:112-7. (Pubitemid 14152453)
12. Harris NL. Hodgkin's lymphomas: classification, diagnosis, and grading. Semin Hematol. 1999;36:220-232. (Pubitemid 29360214)
13. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989;7:1630-1636. (Pubitemid 19272832)
14. Nachman JB, Sposto R, Herzog P, et al. Children's Cancer Group. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol. 2002;20:3765-3771.
15. Johnson PWM, Radford JA, Cullen MH, et al. Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). J Clin Oncol. 2005;23:9208-9218.
16. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463 (Pubitemid 41821197)
17. Van 't Hof AWJ, Schipper CW, Gerritsen JG, et al. Comparison of radionuclide angiography with three echocardiographic parameters of left ventricular function in patients after myocardial infarction. Int J Cardiac Imaging. 1998;14: 413-418.
18. Schwartz RG, McKenzie WB, Alexander J, et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med. 1987;82:1109-1118.
19. Nousiainen T, Jantunen E, Vanninen E, et al. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Br J Cancer. 2002;86: 1697-1700. (Pubitemid 34712910)
20. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer. 2003;97:2869-2879. (Pubitemid 36605157)
21. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808-815.
22. Lipshultz SE, Lipsitz SR, Mone SM, et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med. 1995;332: 1738-1743.
23. Krischer JP, Epstein S, Cuthbertson DD, et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol. 1997;15:1544-1552. (Pubitemid 27167391)
24. Gharib MI, Burnett AK. Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis. Eur J Heart Failure. 2002;4:235-242. (Pubitemid 35190345)
25. Kremer LCM, van Dalen EC, Offringa M, et al. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol. 2002;12:503-512. (Pubitemid 34461132)
26. Kremer LCM, van Dalen EC, Offringa M, et al. Anthracycline- induced clinical heart failure in a cohort of 607 children: long-term follow-up Study. J Clin Oncol. 2001;19:191-196. (Pubitemid 32063496)
27. Von Hoff DD, Layard MW, Basa P, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 1979;91:710-717. (Pubitemid 10218041)
28. Steinherz LJ, Steinherz PG, Tan CT, et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991;266:1672-1677.
29. L'Ecuyer T, Sanjeev S, Thomas R, et al. DNA damage is an early event in doxorubicin-induced cardiac myocyte death. Am J Physiol Heart Circ Physiol. 2006;291:H1273-H1280. (Pubitemid 44343672)
30. Pluim BM, Beyerbacht HP, Chin JC, et al. Comparison of echocardiography with magnetic resonance in the assessment of the athlete's heart. Eur Heart J. 1997;18:1505-1513. (Pubitemid 27389047)
31. Kronik G, Slany J, Mosslacher H. Comparative value of eight M-mode echocardiographic formulas for determining left ventricular stroke volume. Circulation. 1979;60:1308-316.
32. Teichholz LE, Kreulen T, Herman MV, et al. Problems in echocardiographic volume determinations: echocardiographicangiographic correlations in the presence or absence of asynergy. Am J Cardiol. 1976;37:7-11.
33. Nousiainen T, Vanninen E, Jantunen E, et al. Comparison of echocardiography and radionuclide ventriculography in the follow up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy. J Int Med. 2001;249:297-303. (Pubitemid 34293776)
34. Morrison D, Marshall J, Wright AL, et al. An improved method of right ventricular gated equilibrium blood pool radionuclide ventriculography. Chest. 1982;82:607-614. (Pubitemid 13234193)
35. Hoffmann A, Engelfriet P, Mulder B. Radiation exposure during follow-up of adults with congenital heart disease. Int J Cardiol. 2007;118:151-153. (Pubitemid 46601641)
36. Shan K, Lincoff AM, Young JB. Anthracycline induced cardiotoxicity. Ann Intern Med. 1996;125:47-58.
37. Nielsen D, Jensen JB, Dombernowsky P, et al. Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer. J Clin Oncol. 1990;8:806-1810.
38. Lipshultz SE, Sanders SP, Goorin AM, et al. Monitoring for anthracycline cardiotoxicity. Pediatrics. 1994;93:433-437. (Pubitemid 24067017)
39. Jensen BV, Skovsgaard T, Nielsen SL. Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, longterm observational study of outcome in 120 patients. Ann Oncol. 2002;13:699-709. (Pubitemid 34567375)
40. Freedman LS, Edwards BK, Ries LAG, et al. eds. Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared With US SEER. Bethesda, MD: National Cancer Institute; 1996. NIH Publication No. 06-5873.
41. Van Royen N, Jaffe CC, Krumholz HM, et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol. 1996;77:843-850. (Pubitemid 26143494)
42. Kontos MC, Kurdziel K, McQueen R, et al. Comparison of 2-dimensional echocardiography and myocardial perfusion imaging for diagnosing myocardial infarction in emergency department patients. Am Heart J. 2002;143:659-667. (Pubitemid 34454699)
43. Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138-2147.
44. Cwajg E, Cwajg J, He Z, et al. Gated myocardial perfusion tomography for the assessment of left ventricular function and volumes: comparison with echocardiography. J Nucl Med. 1999;40:1857-1865. (Pubitemid 29523580)